Inflammatory Breast Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
Conditions: Breast Neoplasm; Neoplasm MetastasisInterventions: Drug: Monoclonal Antibody 3A1; Drug: Monoclonal Antibody 95-5-49; Drug: Monoclonal Antibody 95-6-22; Device: Baxter Isolex 3001 Stem Cell Selection System; Device: Ceprate SCSponsor: National Cancer Institute (NCI)Completed - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 1999 Category: Research Source Type: clinical trials
